StonvexLoading…
StonvexStonvexStonvexCore line items from CERS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $53.66M | $233.80M | $43.24M | $201.32M |
Operating Income | $-354.00K | $-8.68M | $-5.85M | $-14.22M |
Net Income | $-1.64M | $-15.63M | $-7.72M | $-20.92M |
EPS (Diluted) | $-0.01 | $-0.08 | $-0.04 | $-0.11 |
Total Assets | $222.91M | $221.86M | $206.78M | $200.92M |
Total Liabilities | $154.62M | $156.89M | $150.53M | $144.02M |
Cash & Equivalents | $27.85M | $19.96M | $19.48M | $20.27M |
Free Cash Flow OCF − CapEx | $-3.28M | $1.11M | $-956.00K | $8.52M |
Shares Outstanding | 194.14M | 192.14M | 187.07M | 185.77M |